Hyposmia and executive dysfunction as predictors of future Parkinson's disease: a prospective study

Ponsen, Mirthe M., Stoffers, Diederick, Twisk, Jos W.R., Wolters, Erik Ch., Berendse, Henk W.·2009·Movement Disorders
DOI 10.1002/mds.22534

Cited by (127)

Items 101–127 of 127

  1. [Analysis of clinical characteristics in the patient with olfactory disorders].
    Jia Liu, Xiaojun Zhan, Linyin Yao, Hongbo Xie, Feifan Chang · 2022 · PubMed Central
  2. Pathological considerations in the treatment of Parkinson's disease: More than just a wiring diagram
    Carrie B. Hurelbrink, Simon J.G. Lewis · 2010 · Clinical Neurology and Neurosurgery
  3. The Importance of Olfactory and Motor Endpoints for Zebrafish Models of Neurodegenerative Disease
    Angela L. Shamchuk, Keith B. Tierney · 2013 · Elsevier eBooks
  4. Clinical Assessment of Olfactory Disorders
    Tuğba Koçak, Aytuğ Altundağ, Thomas R. Hummel · 2019 · Springer eBooks
  5. The Importance of Olfactory and Motor Endpoints for Zebrafish Models of Neurodegenerative Disease
    Angela L. Shamchuk, W. Ted Allison, Keith B. Tierney · 2017 · Elsevier eBooks
  6. Olfactory Dysfunction
    Andreas Puschmann, Zbigniew K. Wszołek · 2012 · Humana Press eBooks
  7. Impact of deep brain stimulation (DBS) on olfaction in Parkinson's disease: Clinical features and functional hypotheses
    Gérard Brand, Charlotte Bontempi, Laurence Jacquot · 2023 · Revue Neurologique
  8. Le système olfactif
    Nicolas Leboucq, Nicolas Menjot de Champfleur, S. Menjot de Champfleur, Alain Bonafé · 2013 · Journal de radiologie diagnostique et interventionnelle
  9. Olfaction in Parkinson’s Disease – A Clinical Approach
    Antje Haehner, Thomas R. Hummel, Heinz Reichmann · 2020 · European Neurological Review
  10. Olfaction
    Caroline Huart, P Eloy, Philippe Rombaux · 2023 · Springer eBooks
  11. Desarrollo de una prueba de identificación de olores de amplia disponibilidad
    Sara Robledo-Rengifo, María del Pilar Agudelo Uribe, Juan Manuel Ospina-Giraldo, Juan Sebastián Saavedra-Moreno, Sandra Patricia Isaza-Jaramillo · 2022 · Neurología, Neurocirugía y Psiquiatría
  12. Nonmotor problems in Parkinson disease
    Stanley Fahn, Joseph J. Jankovic, Mark Hallett · 2011 · Elsevier eBooks
  13. The Emerging Entity of Pre‐Motor Parkinson's Disease
    J. William Langston · 2011 · Parkinson s Disease
  14. Combinations of Markers Provide Clues to the Underlying Neurodegenerative Disorder in REM Sleep Behavior Disorder
    Tomoyuki Miyamoto, Masayuki Miyamoto · 2011 · InTech eBooks
  15. Características Neuropsicológicas y Aproximación Diagnóstica a la Demencia Parkinson y a la Demencia por Cuerpos de Lewy
    Raquel Yubero · 2011 · Revista Española de Geriatría y Gerontología
  16. Coupling biomarkers and drug action for neurodegenerative disease therapies: Does the nose know?
    Fernando Cardozo‐Pelaez, Richard J. Bridges · 2012 · Experimental Neurology
  17. The role of alpha-synuclein phosphorylation in synucleinopathies
    Elisa Basso · 2014 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  18. Targeting the Gut-Brain axis in Parkinson's disease
    Paula Perez‐Pardo · 2017 · Utrecht University Repository (Utrecht University)
  19. Transkranieller Ultraschall und dreidimensionale Bewegungsanalyse zur Identifikation einer Risikogruppe für Morbus Parkinson
    Christian Bormann · 2015 · Universitätsbibliothek Tübingen
  20. Microbiota and Parkinson's disease (overview)
    R. R. Tyutina, Anna A. Pilipovich, В Л Голубев, Alexey B. Danilov · 2020 · Medical alphabet
  21. Clinical Trials for Disease-Modifying Agents in Parkinson’s Disease
    Orlando Artavia, Lana M. Chahine · 2020 · Neuromethods
  22. Nonmotor problems in Parkinson disease
    Joseph J. Jankovic, Mark Hallett, Michael S. Okun, Cynthia L. Comella, Stanley Fahn, Jennifer G. Goldman · 2021 · Elsevier eBooks
  23. Sex and LRRK2 Genotype Differences in Inflammation and Dopaminergic Neurodegeneration in a Multi-Hit Model of Parkinson's Disease
    Shannon Bellevue · 2016
  24. Impact moléculaire de l’exposition subchronique par voie orale à un pesticide, le paraquat, dans un modèle murin transgénique de synucléinopathie humaine : implication du système nerveux entérique
    Nicolas Naudet · 2017 · theses.fr (ABES)
  25. Contribution des interneurones cholinergiques striataux aux déficits cognitifs de la maladie de Parkinson : approches optogénétique et comportementale chez la souris
    Juliette Lhost · 2020 · theses.fr (ABES)
  26. Transcriptional changes in the peripheral blood of at-risk individuals without clinical manifestation of Parkinson’s Disease
    Benjamin J. Whittle, C. Chen, Ossagie Izuogu, Michael S. Jackson, Mauro Santibanez‐Koref, Gavin Hudson · 2026 · Research Square
  27. Plastamination in Human Brain: The Possible Role of Microplastics in Neuroinflammation and Parkinson’s Disease
    Ezia Guatteo, Maria Zelinda Romano, Nicola Berretta, Mario Ruggiero, Antonietta Santoro, Filomena Mazzeo, Rosaria Meccariello · 2026 · Microplastics